| NCT Number | NCT07456436 |
| Lead Sponsor | University of Southern California
Collaborators: National Cancer Institute (NCI), Merck Sharp & Dohme LLC |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 50 participants |
| Start Date | 2024-11-26 |
| Primary Completion | 2026-11-26 (estimated) |
| Study Completion | 2027-11-26 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-13 |